# Ralexar Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ralexar-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Wayne, US
- Website: www.linkedin.com/company/ralexar-therapeutics/
- Total disclosed funding: $22M
- Latest round: Series A (Jan 2, 2014)
- Investors on record: 3

## About

Ralexar Therapeutics, Inc. focuses on developing innovative therapies that target specific diseases by leveraging advanced biological research and technology.Founded in 2014 and headquartered in Wayne, US, Alexar Therapeutics, Inc. specializes in creating therapeutic solutions. New Science Ventures and Third Point exited its stake in Ralexar Therapeutics, Inc. Ralexar Therapeutics, Inc. specializes in developing innovative therapies aimed at addressing specific medical conditions. Their core services include research-driven development of therapeutic solutions that leverage biological insights to enhance patient outcomes. Ralexar Therapeutics, Inc. generates revenue through its proprietary therapeutic development initiatives, which involve extensive research and strategic partnerships to bring new therapies to market based on clinical needs.

## Funding rounds

- Series A, Jan 2, 2014, $22M — Third Point, Palo Alto Investors, New Science Ventures

## Investors

- Third Point (https://capitalatlas.ai/funds/third-point) — Series A
- Palo Alto Investors (https://capitalatlas.ai/funds/palo-alto-investors) — Series A
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A